Laura Buggio

ORCID: 0000-0002-1199-1888 · 69 papers in corpus
review 2020
Journal of Psychosomatic Research ·doi:10.1016/j.jpsychores.2020.110213

OBJECTIVE: To summarize the available qualitative and quantitative evidence regarding the impact of endometriosis on women's partners. METHODS: A systematic electronic search of PubMed and PsycINFO was conducted. All the available evidence…

other 2020
Fertility and sterility ·doi:10.1016/j.fertnstert.2020.09.001

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Authors. The entire group of …

observational 2019
Journal of health psychology ·doi:10.1177/1359105319863093

In this study, we examined whether beliefs regarding motherhood, female identity, and infertility affected the psychological health of 127 childless endometriosis patients. Anxiety and depression were measured using the Hospital Anxiety and…

review 2019
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2018.1549213

The incidence of endometriosis in middle-aged women is not minimal compared to that in the reproductive age group. The treatment of affected women after childbearing age to the natural transition toward menopause has received considerably p…

other 2019
The Journal of clinical endocrinology and metabolism ·doi:10.1210/jc.2018-02494
observational 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719118766259

The immunomodulatory, anti-inflammatory, and antiproliferative properties of vitamin D have laid the basis for a possible function of this prohormone in the pathogenesis of endometriosis. The aim of this case-control study was to investigat…

review 2018
Minerva ginecologica ·doi:10.23736/s0026-4784.17.04163-6

Adenomyosis is a benign condition characterized by the presence of endometrial glands and stroma deep within the myometrium. In recent years, the potential negative impact of adenomyosis on in vitro fertilization clinical outcomes has gaine…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey368

Elagolix, an orally active non-peptidic GnRH antagonist, has been approved by the Food and Drug Administration for the management of moderate to severe pain associated with endometriosis. As the degree of ovarian suppression obtained with e…

nonrandomized-trial 2018
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719117749759

The purpose of this study was to assess the proportion of patients satisfied with their treatment after a change from a low-dose oral contraceptive (OC) to norethisterone acetate (NETA) because of inefficacy of OC on pain symptoms. To this …

review 2018
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13328

A comprehensive literature review was performed to evaluate the effect of various hormonal therapies, in terms of variations of intestinal and pain complaints and of patient satisfaction with treatment, in women with symptomatic, non-severe…

review 2018
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2018.01.015

Available medical treatments for symptomatic endometriosis act by inhibiting ovulation, reducing serum oestradiol levels, and suppressing uterine blood flows. For this, several drugs can be used with a similar magnitude of effect, in terms …

review 2018
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2018.01.017

In women with endometriosis, the lifetime risk of ovarian cancer is increased from 1.4% to about 1.9%. The risk of clear cell and endometrioid ovarian cancer is, respectively, tripled and doubled. Atypical endometriosis, observed in 1-3% of…

observational 2018
Gynecologic and obstetric investigation ·doi:10.1159/000494254

AIMS: The economic burden of endometriosis and pelvic pain involves direct and indirect healthcare costs due to work loss and decreased productivity. However, the relation between endometriosis, pelvic pain, and employment remains underinve…

nonrandomized-trial 2018
Gynecologic and obstetric investigation ·doi:10.1159/000486335

BACKGROUND/AIMS: Oral contraceptives (OC) and norethisterone acetate (NETA) are among first-line medical therapies for symptomatic endometriosis, but their use is sometimes associated with intolerable side effects. We investigated whether s…

case-report 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.04.004

OBJECTIVE: To describe our technique for laparoscopic management of post-cesarean section isthmocele. DESIGN: Surgical video article. Local Institutional Review Board approval for the video reproduction has been obtained. SETTING: Univers…

review 2017
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC ·doi:10.1016/j.jogc.2017.07.011

Endometriosis management seems to be influenced by outcome-independent biomedical, pharmacological, and technological developments. The propensity towards doing more affects several aspects of care, sometimes translating into proposals that…

observational 2017
Human Reproduction ·doi:10.1093/humrep/dex249

STUDY QUESTION: What factors affect the mental health of women with endometriosis? SUMMARY ANSWER: Not only pelvic pain, but also individual characteristics (i.e. self-esteem, body esteem and emotional self-efficacy), time from diagnosis a…

review 2017
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2017.05.010

Despite higher costs for robotic-assisted laparoscopy (RAL) than standard laparoscopy (SL), RAL treatment of endometriosis is performed without established indications. PubMed/MEDLINE was searched for 'robotic surgery' and 'endometriosis' o…

review 2017
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2017.1381086

Endometriosis is an estrogen-dependent chronic inflammatory disorder that requires a life-long management plan. Long-term adherence to treatment is pivotal to ensure an effective clinical management. In this optic, one of the cornerstone of…

review 2017
Archives of gynecology and obstetrics ·doi:10.1007/s00404-017-4448-z

PURPOSE: We aim to provide a comprehensive overview of the role of the vagina as a route for drug delivery and absorption, with a particular focus on the use of vaginal hormonal compounds for the treatment of deep infiltrating symptomatic e…

review 2017
Fertility and sterility ·doi:10.1016/j.fertnstert.2017.08.038

Defining whether medical therapy is effective in women with deep rectovaginal endometriosis and in which circumstances it can be considered an alternative to surgery is important for patients and physicians. Numerous observational and some …

review 2017
International journal of women's health ·doi:10.2147/ijwh.s119724

Endometriosis has a multifactorial etiology. The onset and progression of the disease are believed to be related to different pathogenic mechanisms. Among them, the environment and lifestyle may play significant roles. Diet, dietary supplem…

other 2017
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.14789

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

review 2017
Expert review of pharmacoeconomics & outcomes research ·doi:10.1080/14737167.2018.1411803

KEYWORDS: Endometriosispelvic painmedical therapysurgerylaparoscopylow-value careminimally disruptive medicinetreatment burden

2017
·doi:10.26226/morressier.5912d9e8d462b80292386e4d